Canine Hepatozoonosis: Treatment and Prevention in Veterinary Practice

Management of Hepatozoon canis infection requires attention to both the parasite and the conditions that may accompany it. Clinical severity can vary considerably, from subclinical infection to severe disease associated with high parasitaemia. Treatment decisions therefore need to be considered alongside the dog's clinical condition, parasitaemia, and possible co-infections. Because ticks are central to transmission, reducing exposure is equally important for limiting further infection. 

Imidocarb as the Main Therapeutic Option¹ 

Imidocarb dipropionate is described as the preferred treatment for canine H. canis infection. The reported dosage is 5–6 mg/kg, administered either subcutaneously or intramuscularly, with treatment repeated every 14 days until gamonts are no longer detected in the bloodstream. 

In many cases, one or two injections may be sufficient, although more severe infections may require treatment for approximately eight weeks. The response can vary with the level of parasitic infection and the presence of concurrent disease. 

For the practicing veterinarian, monitoring the bloodstream for persistence of gamonts is particularly relevant when determining whether further treatment is required. 

Addressing Possible Co-infections 

Tick exposure can complicate the clinical picture because dogs may simultaneously harbor other tick-borne infections. Doxycycline may therefore be used alongside imidocarb when concurrent infection is a concern. The reported regimen in the provided content is 10 mg/kg orally once daily for 21 days. 

The importance of recognizing co-infection is illustrated by a reported dog simultaneously infected with Ehrlichia canis and H. canis. Despite treatment with Ringer's solution, 5% glucose, Imizol, Injectavit, Ketozal, nandrolone, doxycycline, and a blood transfusion, the dog's condition did not improve. It ultimately progressed to vomiting with blood, melena, and death². 

This highlights why persistent or severe clinical signs should not automatically be attributed to H. canis alone. 

Other Treatment Regimens 

Alternative therapeutic approaches have also been reported. One infected dog treated with toltrazuril combined with trimethoprim-sulfamethoxazole showed improvement in clinical signs and elimination of H. canis gametocytes from the blood¹. 

Another reported regimen used tetracycline hydrochloride at 22 mg/kg three times daily, together with imidocarb dipropionate at 6 mg/kg subcutaneously, with the imidocarb treatment repeated after 14 days. Clinical improvement and reduced gametocyte detection were observed following this approach³. 

These reported responses indicate that treatment outcomes can vary, particularly according to infection severity and accompanying disease. 

Prognosis Depends on Disease Severity 

Dogs with low levels of parasitic infection generally have a higher likelihood of recovery. Prognosis becomes more uncertain when parasitaemia is high or when other diseases are present. Clinical monitoring should therefore extend beyond parasite detection and include the patient's overall response and concurrent abnormalities. 

Prevention Starts with Tick Control¹ 

Because ticks are the principal carriers of H. canis, controlling tick exposure is central to prevention. Acaricides can be used to reduce tick populations, although they target ticks rather than directly preventing transmission of the parasite. Regular cleaning and grooming can also help reduce the likelihood of dogs ingesting attached ticks. 

There is currently no specific vaccine available for H. canis. Preventive attention should therefore focus on reducing exposure to infected ticks. 

Additional Preventive Considerations 

Transplacental transmission has been reported, making infection status relevant when managing breeding animals. Treatment of infected dogs before breeding may help address this potential route of transmission. 

Because transmission through infected tissues has also been reported, avoiding raw meat feeding may be advisable for dogs living in areas where infection is common. 

Practical Clinical Insight 

Effective management of canine hepatozoonosis requires a combined approach: treat the infection appropriately, investigate concurrent tick-borne disease when clinically indicated, monitor response, and maintain consistent tick-control measures. Prevention cannot rely on vaccination at present, making tick exposure reduction, grooming, and attention to breeding and dietary practices important components of long-term management. 

References 

1. Hasani SJ, Rakhshanpour A, Enferadi A, Sarani S, Samiei A, Esmaeilnejad B. A review of Hepatozoonosis caused by Hepatozoon canis in dogs. Journal of Parasitic Diseases. 2024 Sep;48(3):424-38. https://pmc.ncbi.nlm.nih.gov/articles/PMC11319582/pdf/12639_2024_Article_1682.pdf 

2. Tsachev I, Ivanov A, Dinev I, Simeonova G, Kanakov D. Clinical Ehrlichia canis and Hepatozoon canis co-infection in a dog in Bulgaria. Revue de Médecine Vétérinaire. 2008 Feb 1;159(2):68. https://www.academia.edu/download/78108339/Clinical_Ehrlichia_canis_and_Hepatozoon_20220105-10055-fbnukd.pdf 

3. Mylonakis ME, Petanides TA, Koutinas AF. Canine hepatozoonosis: an update. Journal of the Hellenic Veterinary Medical Society. 2004;55(2):174-9. https://ejournals.epublishing.ekt.gr/index.php/jhvms/article/download/15191/13664